Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Brevilin A | 16503-32-5 | 1 MG
SDP

Catalog No. 5000421323
Encompass_Preferred

Brevilin A is an orally active STAT3/JAK inhibitor with anti-tumor and anti-proliferative activities against cancer cells. It also induces apoptosis and autophagy, and inhibits STAT3 signaling.

  • Orally active STAT3/JAK inhibitor
  • Demonstrates anti-tumor activity
  • Exhibits anti-proliferative activity against cancer cells
  • Induces apoptosis and autophagy
  • Inhibits STAT3 signaling in a dose-dependent manner
  • Blocks STAT3 tyrosine 705 phosphorylation
  • Inhibits CNE-2 xenograft tumor growth and PI3K/AKT and STAT3 signaling in vivo

Catalog No. 50-004-21323 Supplier Medchemexpress LLC Supplier No. HYN29591MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Brevilin A is an orally active STAT3/JAK inhibitor with anti-tumor and anti-proliferative activities against cancer cells. It also induces apoptosis and autophagy, and inhibits STAT3 signaling.

  • Orally active STAT3/JAK inhibitor
  • Demonstrates anti-tumor activity
  • Exhibits anti-proliferative activity against cancer cells
  • Induces apoptosis and autophagy
  • Inhibits STAT3 signaling in a dose-dependent manner
  • Blocks STAT3 tyrosine 705 phosphorylation
  • Inhibits CNE-2 xenograft tumor growth and PI3K/AKT and STAT3 signaling in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.